| 000 | 01711 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512080921.0 | ||
| 264 | 0 | _c19851101 | |
| 008 | 198511s 0 0 eng d | ||
| 022 | _a0195-668X | ||
| 024 | 7 |
_a10.1093/oxfordjournals.eurheartj.a061879 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Caterina, R | |
| 245 | 0 | 0 |
_aLow-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet function. _h[electronic resource] |
| 260 |
_bEuropean heart journal _cMay 1985 |
||
| 300 |
_a409-17 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 | _aBleeding Time |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aCyclooxygenase Inhibitors |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
| 650 | 0 | 4 |
_aThromboxane A2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThromboxane B2 _xantagonists & inhibitors |
| 700 | 1 | _aGiannessi, D | |
| 700 | 1 | _aBernini, W | |
| 700 | 1 | _aGazzetti, P | |
| 700 | 1 | _aMichelassi, C | |
| 700 | 1 | _aL'Abbate, A | |
| 700 | 1 | _aDonato, L | |
| 700 | 1 | _aPatrignani, P | |
| 700 | 1 | _aFilabozzi, P | |
| 700 | 1 | _aPatrono, C | |
| 773 | 0 |
_tEuropean heart journal _gvol. 6 _gno. 5 _gp. 409-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/oxfordjournals.eurheartj.a061879 _zAvailable from publisher's website |
| 999 |
_c3935932 _d3935932 |
||